Prosensa Strengthens its Management Team and Supervisory Board with Key Appointments
June 30, 2014 08:00 ET
|
Prosensa Holding N.V.
Leiden, The Netherlands, June 30, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA) the Dutch biopharmaceutical
company focusing on rare diseases with a high unmet medical need,
today...
Prosensa Awarded $200,000 Research Grant from PPMD
June 27, 2014 08:00 ET
|
Prosensa Holding N.V.
Leiden, The Netherlands, June 27, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA), the Dutch biopharmaceutical
company focusing on RNA-modulating therapeutics for rare diseases
with high...
Prosensa Completes Enrollment in Natural History Study of Duchenne Muscular Dystrophy
June 25, 2014 08:00 ET
|
Prosensa Holding N.V.
Leiden, The Netherlands, June 25, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA), the Dutch biopharmaceutical
company focusing on RNA-modulating therapeutics for rare diseases
with high...
Prosensa's Hans Schikan Appointed to the Biotechnology Industry Organization's Emerging Companies Section Governing Board
June 23, 2014 18:33 ET
|
Prosensa Holding N.V.
San Diego, CA, June 23, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA) the Dutch biopharmaceutical
company focusing on rare diseases with a high unmet medical need,
today announced that...
Prosensa to Present at the JMP Securities HealthCare Conference
June 19, 2014 08:00 ET
|
Prosensa Holding N.V.
Leiden, The Netherlands, June 19, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA) today announced that Hans
Schikan, Chief Executive Officer, will present a corporate overview
at the JMP...
Prosensa Announces Regulatory Path Forward for Drisapersen as a Potential Treatment for DMD
June 03, 2014 07:00 ET
|
Prosensa Holding N.V.
Leiden, The Netherlands, June 3, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA) the Dutch
biopharmaceutical company focusing on rare diseases with a high
unmet medical need, today...
Prosensa to Present at the Jefferies 2014 Global Healthcare Conference
May 28, 2014 11:04 ET
|
Prosensa Holding N.V.
Leiden, The Netherlands, May 28, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA) today announced that Luc
Dochez, Chief Business Officer, will present a corporate overview
at the...
Prosensa Announces 1st Quarter 2014 Financial Results and Recent Corporate Developments
May 20, 2014 07:00 ET
|
Prosensa Holding N.V.
LEIDEN, The Netherlands, May 20, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (Nasdaq:RNA), the Dutch biopharmaceutical company focusing on RNA-modulating therapeutics for rare diseases with high...
Prosensa Announces Shareholder Meeting
May 19, 2014 08:00 ET
|
Prosensa Holding N.V.
Leiden, The Netherlands, May 19, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA), today announced that a
General Meeting of Shareholders will be held on June 17, 2014 at
14:00 CET, at the...
Prosensa Holding N.V. to Webcast Conference Call Discussing 1st Quarter 2014 Financial Results and Corporate Update on May 20, 2014
May 13, 2014 08:57 ET
|
Prosensa Holding N.V.
Leiden, The Netherlands, May 13, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA) today announced that the
Company will host a conference call and live audio webcast on
Tuesday, May 20,...